{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:35:15Z","timestamp":1780097715063,"version":"3.54.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pharos University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to assess salivary and seroprevalence of <jats:italic>Toxoplasma<\/jats:italic> immunoglobulins in risky populations and evaluate drug docking targeting TgERP. A cross-sectional study was conducted in Alexandria University hospitals\u2019 outpatient clinics. 192 participants were enrolled from September 2022 to November 2023. Anti-<jats:italic>Toxoplasma<\/jats:italic> IgG and IgM were determined in serum and saliva by ELISA. An in-Silico study examined TgERP\u2019s protein\u2013protein interactions (PPIs) with pro-inflammatory cytokine receptors, anti-inflammatory cytokine, cell cycle progression regulatory proteins, a proliferation marker, and nuclear envelope integrity-related protein Lamin B1. Our findings revealed that anti-<jats:italic>T. gondii<\/jats:italic> IgG were detected in serum (66.1%) and saliva (54.7%), with 2.1% of both samples were positive for IgM. Salivary IgG had 75.59% sensitivity, 86.15% specificity, 91.40% PPV, 64.40% NPP, 79.17% accuracy and fair agreement with serum IgG. On the other hand, the sensitivity, specificity, PPV, NPV, and accuracy in detecting salivary IgM were 75.0%, 99.47%, 75.0%, 99.47%, and 98.96%. AUC 0.859 indicates good discriminatory power. Examined synthetic drugs and natural products can target specific amino acids residues of TgERP that lie at the same binding interface with LB1 and Ki67, subsequently, hindering their interaction. Hence, salivary samples can be a promising diagnostic approach. The studied drugs can counteract the pro-inflammatory action of TgERP.<\/jats:p>","DOI":"10.1038\/s41598-024-63735-z","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:01:25Z","timestamp":1718244085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In silico study to explore the mechanism of Toxoplasma-induced inflammation and target therapy based on sero and salivary Toxoplasma"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2964-4606","authenticated-orcid":false,"given":"Faika","family":"Hassanein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewida H.","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany I.","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Alaa","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas M.","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"63735_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2019.e00037","volume":"15","author":"S Stelzer","year":"2019","unstructured":"Stelzer, S. et al. Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact. Food Waterborne Parasitol. 15, e00037. https:\/\/doi.org\/10.1016\/j.fawpar.2019.e00037 (2019).","journal-title":"Food Waterborne Parasitol."},{"issue":"6","key":"63735_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cmi.2020.01.008","volume":"26","author":"A Rostami","year":"2020","unstructured":"Rostami, A. et al. Global prevalence of latent toxoplasmosis in pregnant women: A systematic review and meta-analysis. Clin. Microbiol. Infect. 26(6), 673\u2013683. https:\/\/doi.org\/10.1016\/j.cmi.2020.01.008 (2020).","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"63735_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.actatropica.2012.08.005","volume":"124","author":"HK El Deeb","year":"2012","unstructured":"El Deeb, H. K., Salah-Eldin, H., Khodeer, S. & Allah, A. A. Prevalence of Toxoplasma gondii infection in antenatal population in Menoufia governorate, Egypt. Acta Trop. 124(3), 185\u2013191. https:\/\/doi.org\/10.1016\/j.actatropica.2012.08.005 (2012).","journal-title":"Acta Trop."},{"issue":"9","key":"63735_CR4","doi-asserted-by":"publisher","first-page":"e00505","DOI":"10.1128\/JCM.00505-20","volume":"58","author":"A Teimouri","year":"2020","unstructured":"Teimouri, A., Mohtasebi, S., Kazemirad, E. & Keshavarz, H. Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J. Clin. Microbiol. 58(9), e00505-e520. https:\/\/doi.org\/10.1128\/JCM.00505-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"63735_CR5","volume":"16","author":"K Koutsoumanis","year":"2018","unstructured":"Koutsoumanis, K. et al. Public health risks associated with food-borne parasites. EFSA J. 16, e05495 (2018).","journal-title":"EFSA J."},{"key":"63735_CR6","doi-asserted-by":"publisher","first-page":"894573","DOI":"10.3389\/fped.2022.894573","volume":"10","author":"L Bollani","year":"2022","unstructured":"Bollani, L. et al. Congenital toxoplasmosis: The state of the art. Front. Pediatr. 10, 894573. https:\/\/doi.org\/10.3389\/fped.2022.894573 (2022).","journal-title":"Front. Pediatr."},{"key":"63735_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2019.e00049","volume":"15","author":"K Shapiro","year":"2019","unstructured":"Shapiro, K. et al. Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food. Food Waterborne Parasitol. 15, e00049. https:\/\/doi.org\/10.1016\/j.fawpar.2019.e00049 (2019).","journal-title":"Food Waterborne Parasitol."},{"issue":"1","key":"63735_CR8","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","volume":"12","author":"SG Sanchez","year":"2021","unstructured":"Sanchez, S. G. & Besteiro, S. The pathogenicity and virulence of Toxoplasma gondii. Virulence 12(1), 3095\u20133114. https:\/\/doi.org\/10.1080\/21505594.2021.2012346 (2021).","journal-title":"Virulence"},{"key":"63735_CR9","doi-asserted-by":"publisher","DOI":"10.24017\/science.2020.ICHMS2020.8","author":"HMSh Saadi","year":"2020","unstructured":"Saadi, H. MSh. & Ahmed, A. J. Sero-epidemiological study of Toxoplasma gondii among pregnant women in Akre City. Kurd. J. Appl. Res. https:\/\/doi.org\/10.24017\/science.2020.ICHMS2020.8 (2020).","journal-title":"Kurd. J. Appl. Res."},{"issue":"5","key":"63735_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10096-019-03487-1","volume":"38","author":"X Li","year":"2019","unstructured":"Li, X. et al. Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision. Eur. J. Clin. Microbiol. Infect. Dis. 38(5), 883\u2013890. https:\/\/doi.org\/10.1007\/s10096-019-03487-1 (2019).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"63735_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s13071-022-05620-0","volume":"15","author":"SC Xie","year":"2022","unstructured":"Xie, S. C. et al. A combined miRNA-piRNA signature in the serum and urine of rabbits infected with Toxoplasma gondii oocysts. Parasites Vectors 15(1), 490. https:\/\/doi.org\/10.1186\/s13071-022-05620-0 (2022).","journal-title":"Parasites Vectors"},{"issue":"2","key":"63735_CR12","first-page":"429","volume":"32","author":"MS Mahmoud","year":"2002","unstructured":"Mahmoud, M. S. Detection of Toxoplasma gondii antigens in urine by reverse latex agglutination test during human toxoplasmosis. J. Egypt. Soc. Parasitol. 32(2), 429\u2013446 (2002).","journal-title":"J. Egypt. Soc. Parasitol."},{"issue":"5","key":"63735_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1128\/jcm.27.5.1099-1101.1989","volume":"27","author":"J Huskinson","year":"1989","unstructured":"Huskinson, J., Stepick-Biek, P. & Remington, J. S. Detection of antigens in urine during acute toxoplasmosis. J. Clin. Microbiol. 27(5), 1099\u20131101. https:\/\/doi.org\/10.1128\/jcm.27.5.1099-1101.1989 (1989).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"63735_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14411\/fp.2012.004","volume":"59","author":"X Hu","year":"2012","unstructured":"Hu, X., Pan, C. W., Li, Y. F., Wang, H. & Tan, F. Urine sample used for detection of Toxoplasma gondii infection by loop-mediated isothermal amplification (LAMP). Folia Parasitol. 59(1), 21\u201326. https:\/\/doi.org\/10.14411\/fp.2012.004 (2012).","journal-title":"Folia Parasitol."},{"issue":"2","key":"63735_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.17420\/ap6802.426","volume":"68","author":"T Nayeri","year":"2022","unstructured":"Nayeri, T., Sarvi, S. & Daryani, A. Saliva and tear as useful tools for the diagnosis of Toxoplasma gondii in human specimens: A systematic review. Ann. Parasitol. 68(2), 201\u2013213. https:\/\/doi.org\/10.17420\/ap6802.426 (2022).","journal-title":"Ann. Parasitol."},{"issue":"6","key":"63735_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2105\/AJPH.2004.054759","volume":"96","author":"M Morris","year":"2006","unstructured":"Morris, M. et al. Prevalence of HIV infection among young adults in the United States: Results from the Add Health study. Am. J. Public Health 96(6), 1091\u20131097. https:\/\/doi.org\/10.2105\/AJPH.2004.054759 (2006).","journal-title":"Am. J. Public Health"},{"issue":"2","key":"63735_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1590\/s0074-02762006000200006","volume":"101","author":"LA Amado","year":"2006","unstructured":"Amado, L. A. et al. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem. Inst. Oswaldo Cruz 101(2), 149\u2013155. https:\/\/doi.org\/10.1590\/s0074-02762006000200006 (2006).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"1\u20132","key":"63735_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jim.2010.11.005","volume":"364","author":"SM Griffin","year":"2011","unstructured":"Griffin, S. M., Chen, I. M., Fout, G. S., Wade, T. J. & Egorov, A. I. Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J. Immunol. Methods 364(1\u20132), 83\u201393. https:\/\/doi.org\/10.1016\/j.jim.2010.11.005 (2011).","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"63735_CR19","first-page":"237","volume":"17","author":"G Chaushu","year":"1996","unstructured":"Chaushu, G. et al. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies. Bone Marrow Transplant. 17(2), 237\u2013241 (1996).","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"63735_CR20","doi-asserted-by":"publisher","first-page":"O72","DOI":"10.1111\/1469-0691.12295","volume":"20","author":"BF Sampaio","year":"2014","unstructured":"Sampaio, B. F., Macre, M. S., Meireles, L. R. & Andrade, H. F. Jr. Saliva as a source of anti- Toxoplasma gondii IgG for enzyme immunoassay in human samples. Clin. Microbiol. Infect. 20(1), O72\u2013O74. https:\/\/doi.org\/10.1111\/1469-0691.12295 (2014).","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"63735_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/s1473-3099(01)00169-4","volume":"2","author":"A McKie","year":"2002","unstructured":"McKie, A., Vyse, A. & Maple, C. Novel methods for the detection of microbial antibodies in oral fluid. Lancet Infect. Dis. 2(1), 18\u201324. https:\/\/doi.org\/10.1016\/s1473-3099(01)00169-4 (2002).","journal-title":"Lancet Infect. Dis."},{"key":"63735_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1196\/annals.1384.012","volume":"1098","author":"P Brandtzaeg","year":"2007","unstructured":"Brandtzaeg, P. Do salivary antibodies reliably reflect both mucosal and systemic immunity?. Ann. N. Y. Acad. Sci. 1098, 288\u2013311. https:\/\/doi.org\/10.1196\/annals.1384.012 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"63735_CR23","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v5i0.20401","author":"P Brandtzaeg","year":"2013","unstructured":"Brandtzaeg, P. Secretory immunity with special reference to the oral cavity. J. Oral Microbiol. https:\/\/doi.org\/10.3402\/jom.v5i0.20401 (2013).","journal-title":"J. Oral Microbiol."},{"key":"63735_CR24","first-page":"1","volume-title":"Toxoplasma gondii the Model Apicomplexan Perspectives and Methods","author":"JP Dubey","year":"2020","unstructured":"Dubey, J. P. The history and life cycle of Toxoplasma gondii. In Toxoplasma gondii the Model Apicomplexan Perspectives and Methods (eds Weiss, L. M. & Kim, K.) 1\u201319 (Elsevier, 2020)."},{"issue":"2","key":"63735_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1645\/GE-2782.1","volume":"97","author":"D Hill","year":"2011","unstructured":"Hill, D. et al. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J. Parasitol. 97(2), 328\u2013337. https:\/\/doi.org\/10.1645\/GE-2782.1 (2011).","journal-title":"J. Parasitol."},{"issue":"10","key":"63735_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00114-007-0254-y","volume":"94","author":"A Tunnacliffe","year":"2007","unstructured":"Tunnacliffe, A. & Wise, M. J. The continuing conundrum of the LEA proteins. Die Naturwissenschaften 94(10), 791\u2013812. https:\/\/doi.org\/10.1007\/s00114-007-0254-y (2007).","journal-title":"Die Naturwissenschaften"},{"issue":"5","key":"63735_CR27","doi-asserted-by":"publisher","first-page":"H1344","DOI":"10.1152\/ajpheart.01246.2008","volume":"296","author":"J Sun","year":"2009","unstructured":"Sun, J. et al. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina. Am. J. Physiol. Heart Circ. Physiol. 296(5), H1344\u2013H1351. https:\/\/doi.org\/10.1152\/ajpheart.01246.2008 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"63735_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2164-9-118","volume":"9","author":"M Hundertmark","year":"2008","unstructured":"Hundertmark, M. & Hincha, D. K. LEA (late embryogenesis abundant) proteins and their encoding genes in Arabidopsis thaliana. BMC Genom. 9, 118. https:\/\/doi.org\/10.1186\/1471-2164-9-118 (2008).","journal-title":"BMC Genom."},{"key":"63735_CR29","doi-asserted-by":"publisher","first-page":"1125667","DOI":"10.3389\/fimmu.2023.1125667","volume":"14","author":"ZD Vel\u00e1squez","year":"2023","unstructured":"Vel\u00e1squez, Z. D. et al. Dynamics of cell cycle proteins involved in Toxoplasma gondii -induced bovine NET formation. Front. Immunol. 14, 1125667. https:\/\/doi.org\/10.3389\/fimmu.2023.1125667 (2023).","journal-title":"Front. Immunol."},{"issue":"24","key":"63735_CR30","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1101\/gad.179515.111","volume":"25","author":"T Shimi","year":"2011","unstructured":"Shimi, T. et al. The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev. 25(24), 2579\u20132593. https:\/\/doi.org\/10.1101\/gad.179515.111 (2011).","journal-title":"Genes Dev."},{"issue":"5","key":"63735_CR31","doi-asserted-by":"publisher","first-page":"e0130721","DOI":"10.1128\/mBio.01307-21","volume":"12","author":"FJB Miranda","year":"2021","unstructured":"Miranda, F. J. B. et al. Toxoplasma gondii -induced neutrophil extracellular traps amplify the innate and adaptive response. mBio 12(5), e0130721. https:\/\/doi.org\/10.1128\/mBio.01307-21 (2021).","journal-title":"mBio"},{"key":"63735_CR32","doi-asserted-by":"publisher","first-page":"107066","DOI":"10.1016\/j.eplepsyres.2022.107066","volume":"189","author":"Z Shen","year":"2023","unstructured":"Shen, Z. et al. Bioinformatics and network pharmacology analysis of drug targets and mechanisms related to the comorbidity of epilepsy and migraine. Epilepsy Res. 189, 107066. https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.107066 (2023).","journal-title":"Epilepsy Res."},{"issue":"10","key":"63735_CR33","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1093\/cid\/ciaa428","volume":"71","author":"G Milne","year":"2020","unstructured":"Milne, G., Webster, J. P. & Walker, M. Toward improving interventions against toxoplasmosis by identifying routes of transmission using sporozoite-specific serological tools. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 71(10), e686\u2013e693. https:\/\/doi.org\/10.1093\/cid\/ciaa428 (2020).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"3","key":"63735_CR34","first-page":"2","volume":"9","author":"PDV de Almeida","year":"2008","unstructured":"de Almeida, P. D. V. Saliva composition and functions: A comprehensive review. J. Contemp. Dent. Pract. 9(3), 2\u201380 (2008).","journal-title":"J. Contemp. Dent. Pract."},{"key":"63735_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1128\/CDLI.6.5.725-728.1999","volume":"6","author":"MH Korhonen","year":"1999","unstructured":"Korhonen, M. H. et al. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin. Diagn. Lab. Immunol 6, 725\u2013728 (1999).","journal-title":"Clin. Diagn. Lab. Immunol"},{"key":"63735_CR36","first-page":"729","volume-title":"Essential of Medical Microbiology","author":"WA Volk","year":"1982","unstructured":"Volk, W. A. Essential of Medical Microbiology 2nd edn, 729 (G.B.Lippincott Company, 1982).","edition":"2"},{"issue":"23","key":"63735_CR37","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M. & Vangone, A. PRODIGY: A web server for predicting the binding affinity of protein-protein complexes. Bioinformatics 32(23), 3676\u20133678. https:\/\/doi.org\/10.1093\/bioinformatics\/btw514 (2016).","journal-title":"Bioinformatics"},{"key":"63735_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-0716-0708-4_9","volume":"2165","author":"A Alekseenko","year":"2020","unstructured":"Alekseenko, A., Ignatov, M., Jones, G., Sabitova, M. & Kozakov, D. Protein-protein and protein-peptide docking with ClusPro server. Methods Mol. Biol. 2165, 157\u2013174. https:\/\/doi.org\/10.1007\/978-1-0716-0708-4_9 (2020).","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"63735_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.str.2020.06.006","volume":"28","author":"IT Desta","year":"2020","unstructured":"Desta, I. T., Porter, K. A., Xia, B., Kozakov, D. & Vajda, S. Performance and its limits in rigid body protein-protein docking. Structure 28(9), 1071\u20131081. https:\/\/doi.org\/10.1016\/j.str.2020.06.006 (2020).","journal-title":"Structure"},{"key":"63735_CR40","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1186\/1471-2105-12-S1-S33","volume":"12","author":"KC Hsu","year":"2011","unstructured":"Hsu, K. C., Chen, Y. F., Lin, S. R. & Yang, J. M. iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinform. 12, S33. https:\/\/doi.org\/10.1186\/1471-2105-12-S1-S33 (2011).","journal-title":"BMC Bioinform."},{"issue":"W1","key":"63735_CR41","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M. & Marcatili, P. BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 45(W1), W24\u2013W29. https:\/\/doi.org\/10.1093\/nar\/gkx346 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"63735_CR42","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res 48(W1), W449\u2013W454. https:\/\/doi.org\/10.1093\/nar\/gkaa379 (2020).","journal-title":"Nucleic Acids Res"},{"key":"63735_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41182-016-0018-5","volume":"44","author":"I Ayi","year":"2016","unstructured":"Ayi, I. et al. Toxoplasma gondii infections among pregnant women, children and HIV-seropositive persons in Accra, Ghana. Trop. Med. Health 44, 17. https:\/\/doi.org\/10.1186\/s41182-016-0018-5 (2016).","journal-title":"Trop. Med. Health"},{"key":"63735_CR44","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1590\/S1678-9946201961048","volume":"61","author":"MS Macre","year":"2019","unstructured":"Macre, M. S., Meireles, L. R., Sampaio, B. F. C. & Andrade J\u00fanior, H. F. Saliva collection and detection of anti-T. gondii antibodies of low-income school-age children as a learning strategy on hygiene, prevention and transmission of toxoplasmosis. Rev. Inst. Med. Trop. Sao Paulo 61, e48. https:\/\/doi.org\/10.1590\/S1678-9946201961048 (2019).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"8","key":"63735_CR45","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3201\/eid2408.180045","volume":"24","author":"F Robert-Gangneux","year":"2018","unstructured":"Robert-Gangneux, F. et al. Toxoplasmosis in transplant recipients, Europe, 2010\u20132014. Emerg. Infect. Dis. 24(8), 1497\u20131504. https:\/\/doi.org\/10.3201\/eid2408.180045 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"63735_CR46","doi-asserted-by":"publisher","first-page":"6670219","DOI":"10.1155\/2021\/6670219","volume":"2021","author":"B Singh","year":"2021","unstructured":"Singh, B., Debrah, L. B., Acheampong, G. & Debrah, A. Y. Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Kumasi: A cross-sectional study at a district-level hospital, Ghana. Infect. Dis. Obstet. Gynecol. 2021, 6670219. https:\/\/doi.org\/10.1155\/2021\/6670219 (2021).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"12","key":"63735_CR47","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1017\/S0950268816000960","volume":"144","author":"BM Mangiavacchi","year":"2016","unstructured":"Mangiavacchi, B. M., Vieira, F. P., Bahia-Oliveira, L. M. & Hill, D. Salivary IgA against sporozoite-specific embryogenesis-related protein (TgERP) in the study of horizontally transmitted toxoplasmosis via T. gondii oocysts in endemic settings. Epidemiol. Infect. 144(12), 2568\u20132577. https:\/\/doi.org\/10.1017\/S0950268816000960 (2016).","journal-title":"Epidemiol. Infect."},{"issue":"2","key":"63735_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/AZMJ.AZMJ_53_18","volume":"16","author":"MH Hemida","year":"2018","unstructured":"Hemida, M. H., Shahat, S. A., Bayoumy, A. M. S., Mohamed, K. A. & Hassan, Sh. M. Toxoplasmosis prevalence in Egyptian diabetic patients. Al-Azhar Assiut Med. J. 16(2), 113\u2013116. https:\/\/doi.org\/10.4103\/AZMJ.AZMJ_53_18 (2018).","journal-title":"Al-Azhar Assiut Med. J."},{"key":"63735_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s42269-019-0059-0","volume":"43","author":"HM Khattab","year":"2019","unstructured":"Khattab, H. M., El Bassiouni, S. O., Abuelela, M. H. & Abd Elsalam, D. O. Seroprevalence of\u00a0Toxoplasma gondii\u00a0among a group of Egyptian patients with type I diabetes mellitus. Bull. Natl. Res. Cent. 43, 20. https:\/\/doi.org\/10.1186\/s42269-019-0059-0 (2019).","journal-title":"Bull. Natl. Res. Cent."},{"issue":"1","key":"63735_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.21608\/mid.2022.126484.1258","volume":"4","author":"O Okojokwu","year":"2023","unstructured":"Okojokwu, O., Nwachukwu, E., Ali, M. & Agabi, Y. Seroprevalence of anti-Toxoplasma IgG and IgM among pregnant women attending antenatal clinic in Jos-North, Plateau State, Nigeria. Microbes Infect. Dis. 4(1), 285\u2013295. https:\/\/doi.org\/10.21608\/mid.2022.126484.1258 (2023).","journal-title":"Microbes Infect. Dis."},{"key":"63735_CR51","doi-asserted-by":"publisher","first-page":"8881908","DOI":"10.1155\/2021\/8881908","volume":"2021","author":"Q Asgari","year":"2021","unstructured":"Asgari, Q., Motazedian, M. H., Khazanchin, A., Mehrabani, D. & Naderi Shahabadi, S. High prevalence of Toxoplasma gondii infection in type I diabetic patients. J. Parasitol. Res. 2021, 8881908. https:\/\/doi.org\/10.1155\/2021\/8881908 (2021).","journal-title":"J. Parasitol. Res."},{"key":"63735_CR52","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fcimb.2020.00302","volume":"10","author":"S Xin","year":"2020","unstructured":"Xin, S., Su, R., Jiang, N., Zhang, L. & Yang, Y. Low prevalence of antibodies against Toxoplasma gondii in Chinese populations. Front. Cell. Infect. Microbiol. 10, 302. https:\/\/doi.org\/10.3389\/fcimb.2020.00302 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"63735_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/09674845.2005.11732690","volume":"62","author":"MP Singh","year":"2005","unstructured":"Singh, M. P., Dubey, M. L., Sud, A. & Malla, N. Antibody response to Toxoplasma gondii in saliva samples from human immunodeficiency virus-infected patients. Br. J. Biomed. Sci. 62(2), 81\u201384. https:\/\/doi.org\/10.1080\/09674845.2005.11732690 (2005).","journal-title":"Br. J. Biomed. Sci."},{"key":"63735_CR54","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2017.00389","volume":"8","author":"ZD Wang","year":"2017","unstructured":"Wang, Z. D. et al. Toxoplasma gondii Infection in immunocompromised patients: A systematic review and meta-analysis. Front. Microbiol. 8, 389. https:\/\/doi.org\/10.3389\/fmicb.2017.00389 (2017).","journal-title":"Front. Microbiol."},{"issue":"11","key":"63735_CR55","first-page":"137","volume":"4","author":"MH Hemida","year":"2017","unstructured":"Hemida, M. H., Shahat, S. A., Ams, B. & Mohammad, K. A. Prevalence of toxoplasmosis among diabetic patients. EJPMR 4(11), 137\u2013140 (2017).","journal-title":"EJPMR"},{"issue":"4","key":"63735_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1590\/s0036-46652003000400011","volume":"45","author":"RA Co\u00ealho","year":"2003","unstructured":"Co\u00ealho, R. A., Kobayashi, M. & Carvalho, L. B. Jr. Prevalence of IgG antibodies specific to Toxoplasma gondii among blood donors in Recife, Northeast Brazil. Rev. Inst. Med. Trop. Sao Paulo 45(4), 229\u2013231. https:\/\/doi.org\/10.1590\/s0036-46652003000400011 (2003).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"4","key":"63735_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1179\/136485909X435094","volume":"103","author":"J Kamani","year":"2009","unstructured":"Kamani, J., Mani, A. U., Egwu, G. O. & Kumshe, H. A. Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state Nigeria. Ann. Trop. Med. Parasitol. 103(4), 317\u2013321. https:\/\/doi.org\/10.1179\/136485909X435094 (2009).","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"6","key":"63735_CR58","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00436-009-1350-z","volume":"104","author":"HM Elsheikha","year":"2009","unstructured":"Elsheikha, H. M. et al. Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitol. Res. 104(6), 1471\u20131476. https:\/\/doi.org\/10.1007\/s00436-009-1350-z (2009).","journal-title":"Parasitol. Res."},{"issue":"7","key":"63735_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.apjtm.2015.06.014","volume":"8","author":"K Awoke","year":"2015","unstructured":"Awoke, K., Nibret, E. & Munshea, A. Sero-prevalence and associated risk factors of Toxoplasma gondii infection among pregnant women attending antenatal care at Felege Hiwot Referral Hospital, northwest Ethiopia. Asian Pac. J. Trop. Med. 8(7), 549\u2013554. https:\/\/doi.org\/10.1016\/j.apjtm.2015.06.014 (2015).","journal-title":"Asian Pac. J. Trop. Med."},{"key":"63735_CR60","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946201759090","volume":"59","author":"MV Avelar","year":"2017","unstructured":"Avelar, M. V. et al. Association between seroprevalence of IgG anti- Toxoplasma gondii and risk factors for infection among pregnant women in Clim\u00e9rio de Oliveira Maternity, Salvador, Bahia, Brazil. Rev. Inst. Med. Trop. Sao Paulo 59, e90. https:\/\/doi.org\/10.1590\/S1678-9946201759090 (2017).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"63735_CR61","doi-asserted-by":"publisher","first-page":"7311905","DOI":"10.1155\/2022\/7311905","volume":"2022","author":"SA Khabisi","year":"2022","unstructured":"Khabisi, S. A., Almasi, S. Z. & Zadeh, S. L. Seroprevalence and risk factors associated with Toxoplasma gondii infection in the population referred to rural and urban health care centers in Zahedan, primary referral level, in Southeastern Iran. J. Parasitol. Res. 2022, 7311905. https:\/\/doi.org\/10.1155\/2022\/7311905 (2022).","journal-title":"J. Parasitol. Res."},{"key":"63735_CR62","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268823000808","volume":"151","author":"IHM Friesema","year":"2023","unstructured":"Friesema, I. H. M. et al. Risk factors for acute toxoplasmosis in the Netherlands. Epidemiol. Infect. 151, e95. https:\/\/doi.org\/10.1017\/S0950268823000808 (2023).","journal-title":"Epidemiol. Infect."},{"issue":"1","key":"63735_CR63","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1186\/s12889-017-4941-0","volume":"17","author":"D Iddawela","year":"2017","unstructured":"Iddawela, D., Vithana, S. M. P. & Ratnayake, C. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: A cross sectional study. BMC Public Health 17(1), 930. https:\/\/doi.org\/10.1186\/s12889-017-4941-0 (2017).","journal-title":"BMC Public Health"},{"issue":"3","key":"63735_CR64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1128\/CVI.05486-11","volume":"19","author":"M Sakikawa","year":"2012","unstructured":"Sakikawa, M. et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4466 pregnant women in Japan. Clin. Vaccine Immunol. 19(3), 365\u2013367. https:\/\/doi.org\/10.1128\/CVI.05486-11 (2012).","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"63735_CR65","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/eurpub\/cks075","volume":"23","author":"A Flatt","year":"2013","unstructured":"Flatt, A. & Shetty, N. Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: A re-examination of risk in an ethnically diverse population. Eur. J. Public Health 23(4), 648\u2013652. https:\/\/doi.org\/10.1093\/eurpub\/cks075 (2013).","journal-title":"Eur. J. Public Health"},{"issue":"1","key":"63735_CR66","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13104-016-2206-0","volume":"9","author":"EC Wam","year":"2016","unstructured":"Wam, E. C. et al. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon. BMC Res. Notes 9(1), 406. https:\/\/doi.org\/10.1186\/s13104-016-2206-0 (2016).","journal-title":"BMC Res. Notes"},{"issue":"9","key":"63735_CR67","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1017\/S0950268814002957","volume":"143","author":"EK Abu","year":"2015","unstructured":"Abu, E. K. et al. Infection risk factors associated with seropositivity for Toxoplasma gondii in a population-based study in the Central Region, Ghana. Epidemiol. Infect. 143(9), 1904\u20131912. https:\/\/doi.org\/10.1017\/S0950268814002957 (2015).","journal-title":"Epidemiol. Infect."},{"issue":"10","key":"63735_CR68","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.apjtm.2017.09.012","volume":"10","author":"HM Ibrahim","year":"2017","unstructured":"Ibrahim, H. M., Mohamed, A. H., El-Sharaawy, A. A. & El-Shqanqery, H. E. Molecular and serological prevalence of Toxoplasma gondii in pregnant women and sheep in Egypt. Asian Pac. J. Trop. Med. 10(10), 996\u20131001. https:\/\/doi.org\/10.1016\/j.apjtm.2017.09.012 (2017).","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"1","key":"63735_CR69","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12879-017-2583-6","volume":"17","author":"S Bamba","year":"2017","unstructured":"Bamba, S. et al. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso. BMC Infect. Dis. 17(1), 482. https:\/\/doi.org\/10.1186\/s12879-017-2583-6 (2017).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"63735_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14737\/JOURNAL.JAP\/2017\/4.1.1.8","volume":"4","author":"AM Mandour","year":"2017","unstructured":"Mandour, A. M., Mounib, M., Eldeek, H. E., Ahmad, A. A. & Abdel-Kader, A. Prevalence of congenital toxoplasmosis in pregnant women with complicated pregnancy outcomes in Assiut governorate, Egypt. J. Adv. Parasitol. 4(1), 1\u20138. https:\/\/doi.org\/10.14737\/JOURNAL.JAP\/2017\/4.1.1.8 (2017).","journal-title":"J. Adv. Parasitol."},{"issue":"6","key":"63735_CR71","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/infdis\/126.6.664","volume":"126","author":"JK Frenkel","year":"1972","unstructured":"Frenkel, J. K. & Dubey, J. P. Toxoplasmosis and its prevention in cats and man. J. Infect. Dis. 126(6), 664\u2013673. https:\/\/doi.org\/10.1093\/infdis\/126.6.664 (1972).","journal-title":"J. Infect. Dis."},{"issue":"4","key":"63735_CR72","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1128\/CVI.00512-12","volume":"20","author":"N Chahed Bel-Ochi","year":"2013","unstructured":"Chahed Bel-Ochi, N., Bouratbine, A. & Mousli, M. Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva. Clin. Vaccine Immunol. 20(4), 468\u2013473. https:\/\/doi.org\/10.1128\/CVI.00512-12 (2013).","journal-title":"Clin. Vaccine Immunol."},{"issue":"12","key":"63735_CR73","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/INF.0000000000000901","volume":"34","author":"E Chapey","year":"2015","unstructured":"Chapey, E., Wallon, M., L\u2019Ollivier, C., Piarroux, R. & Peyron, F. Place of interferon-\u03b3 assay for diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 34(12), 1407\u20131409. https:\/\/doi.org\/10.1097\/INF.0000000000000901 (2015).","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"5","key":"63735_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12526","volume":"40","author":"I Ca\u00f1edo-Solares","year":"2018","unstructured":"Ca\u00f1edo-Solares, I. et al. What do anti- Toxoplasma gondii IgA and IgG subclasses in human saliva indicate?. Parasite Immunol. 40(5), e12526. https:\/\/doi.org\/10.1111\/pim.12526 (2018).","journal-title":"Parasite Immunol."},{"key":"63735_CR75","doi-asserted-by":"publisher","first-page":"374696","DOI":"10.1155\/2009\/374696","volume":"2009","author":"J Matowicka-Karna","year":"2009","unstructured":"Matowicka-Karna, J., Dymicka-Piekarska, V. & Kemona, H. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?. Clin. Dev. Immunol. 2009, 374696. https:\/\/doi.org\/10.1155\/2009\/374696 (2009).","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"63735_CR76","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3171\/2014.12.JNS13846","volume":"124","author":"A Ehlert","year":"2016","unstructured":"Ehlert, A. et al. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: A single-center clinical observational study. J. Neurosurg. 124(1), 51\u201358. https:\/\/doi.org\/10.3171\/2014.12.JNS13846 (2016).","journal-title":"J. Neurosurg."},{"key":"63735_CR77","volume-title":"Calcitriol","author":"BE Lung","year":"2024","unstructured":"Lung, B. E., Mowery, M. L. & Komatsu, D. E. E. Calcitriol (StatPearls Publishing, 2024)."},{"key":"63735_CR78","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/B978-012648860-9\/50050-9","volume-title":"Handbook of Developmental Neurotoxicology","author":"JL Schardein","year":"1998","unstructured":"Schardein, J. L. Animal\/human concordance. In Handbook of Developmental Neurotoxicology (eds Slikker, W. & Chang, L. W.) 687\u2013708 (Academic Press, 1998)."},{"issue":"6","key":"63735_CR79","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/ijms20061305","volume":"20","author":"B Salehi","year":"2019","unstructured":"Salehi, B. et al. The therapeutic potential of apigenin. Int. J. Mol. Sci. 20(6), 1305 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"63735_CR80","doi-asserted-by":"publisher","first-page":"681477","DOI":"10.3389\/fphar.2021.681477","volume":"12","author":"EF DeRango-Adem","year":"2021","unstructured":"DeRango-Adem, E. F. & Blay, J. Does oral apigenin have real potential for a therapeutic effect in the context of human gastrointestinal and other cancers?. Front. Pharmacol. 12, 681477. https:\/\/doi.org\/10.3389\/fphar.2021.681477 (2021).","journal-title":"Front. Pharmacol."},{"key":"63735_CR81","doi-asserted-by":"publisher","first-page":"484670","DOI":"10.1155\/2015\/484670","volume":"2015","author":"Z Hu","year":"2015","unstructured":"Hu, Z. et al. Rapid identification and verification of indirubin-containing medicinal plants. Evid. Based Complement. Alternat. Med. 2015, 484670. https:\/\/doi.org\/10.1155\/2015\/484670 (2015).","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"3","key":"63735_CR82","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nsmb.3366","volume":"24","author":"IA Hendriks","year":"2017","unstructured":"Hendriks, I. A. et al. Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation. Nat. Struct. Mol. Biol. 24(3), 325\u2013336. https:\/\/doi.org\/10.1038\/nsmb.3366 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"63735_CR83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0014-5793(95)00888-g","volume":"371","author":"RW MacKintosh","year":"1995","unstructured":"MacKintosh, R. W. et al. The cyanobacterial toxin microcystin binds covalently to cysteine-273 on protein phosphatase 1. FEBS Lett. 371(3), 236\u2013240. https:\/\/doi.org\/10.1016\/0014-5793(95)00888-g (1995).","journal-title":"FEBS Lett."},{"issue":"3","key":"63735_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152022","volume":"11","author":"JJ He","year":"2016","unstructured":"He, J. J. et al. Proteomic profiling of mouse liver following acute Toxoplasma gondii infection. PLoS One 11(3), e0152022. https:\/\/doi.org\/10.1371\/journal.pone.0152022 (2016).","journal-title":"PLoS One"},{"issue":"10","key":"63735_CR85","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/modpathol.3880424","volume":"14","author":"DF Shen","year":"2001","unstructured":"Shen, D. F. et al. Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma. Mod. Pathol. Off. J. U.S. Can. Acad. Pathol. 14(10), 995\u2013999. https:\/\/doi.org\/10.1038\/modpathol.3880424 (2001).","journal-title":"Mod. Pathol. Off. J. U.S. Can. Acad. Pathol."},{"issue":"47","key":"63735_CR86","doi-asserted-by":"publisher","first-page":"44078","DOI":"10.1074\/jbc.M107656200","volume":"276","author":"JT Maynes","year":"2001","unstructured":"Maynes, J. T. et al. Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1. J. Biol. Chem. 276(47), 44078\u201344082. https:\/\/doi.org\/10.1074\/jbc.M107656200 (2001).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"63735_CR87","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/cbic.202000669","volume":"22","author":"F Salvi","year":"2021","unstructured":"Salvi, F. et al. Towards dissecting the mechanism of protein phosphatase-1 inhibition by its C-terminal phosphorylation. Chembiochem 22(5), 834\u2013838. https:\/\/doi.org\/10.1002\/cbic.202000669 (2021).","journal-title":"Chembiochem"},{"issue":"4","key":"63735_CR88","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.immuni.2014.09.016","volume":"41","author":"K Moriwaki","year":"2014","unstructured":"Moriwaki, K. et al. The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 41(4), 567\u2013578. https:\/\/doi.org\/10.1016\/j.immuni.2014.09.016 (2014).","journal-title":"Immunity"},{"issue":"8","key":"63735_CR89","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948779","volume":"21","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Nuclear envelope rupture and NET formation is driven by PKC\u03b1-mediated lamin B disassembly. EMBO Rep. 21(8), e48779. https:\/\/doi.org\/10.15252\/embr.201948779 (2020).","journal-title":"EMBO Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63735-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63735-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63735-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:02:23Z","timestamp":1718244143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63735-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["63735"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-63735-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13600"}}